Vabametkib is a potent tyrosine kinase inhibitor (TKI) with EGFR as its primary target. Vabametkib can be used in research on non-small cell lung cancer (NSCLC)[1].
Molecular Weight:
566.66
CAS Number:
[1571903-56-4]
Formula:
C29H34N12O
Target:
c-Met/HGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted